SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego’s Heron Therapeutics Inc. plans to raise $150 million in a public offering of its common stock.
San Diego biotech AnaptysBio has set the price of its initial public offering, expecting to raise about $60 million from the sale of its common stock.
Local test maker Banyan Biomarkers is partnering with bioMerieux, a French giant in biotechnology, to develop a blood test that would identify traumatic brain injury.
Shares of locally based DexCom Inc. have soared this month following news that patients will have easier access to the medical device maker’s main product.
The Center for Toxicology and Environmental Health, a consulting firm based in Little Rock, Ark., has opened a Southern California office in Carlsbad and has hired a San Diego State University alumnus to run it.
Local cell therapy company Cytori Therapeutics Inc. is acquiring San Antonio-based Azaya Therapeutics for up to $170 million.
Shares of drugmaker aTyr Pharma climbed over 30 percent Wednesday following news that the San Diego firm’s drug should progress quickly through the regulatory process.
Laura Farmer Sherman, president and CEO of Susan G. Komen San Diego, plans to retire at the end of 2017, the organization announced Tuesday.
A prostate cancer treatment center recently opened in La Jolla offering what it touts as a new image-guided treatment with few side effects and a quick recovery time.
Scripps Health is working to widen access to an HMO that now serves only its employees.
Shares of locally-based DexCom Inc. skyrocketed 26 percent January 13 following news that patients will have easier access to the medical device maker’s lead product.
Local biotech Access Biologics has sold a minority stake of the company for $51 million to Barcelona-based pharmaceutical and chemical firm, Grifols.
San Diego biotech AnaptysBio has hired a chief financial officer and signaled to the U.S. Securities and Exchange Commission that it plans to go public.
The University of California, San Diego will receive $10.5 million from Switzerland’s Family Larsson-Rosenquist Foundation to research the mysteries of human breast milk.